Daiichi Sankyo and Merck Withdraw Ifinatamab Deruxtecan BLA; MRK Stock Reacts
Daiichi Sankyo and Merck Withdraw Ifinatamab Deruxtecan BLA; MRK Stock Reacts GuruFocus
Covered in this story
What has happened since
- Merck & Co. is down 1.0% since this was published, 3 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $MRK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Merck & Co. →Dalsna Finance is currently tracking 36 stories mentioning Merck & Co., the earliest published 7 Apr 2026.
Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.